Refractory Overactive Bladder: How to Select 3rd Line Therapies and Optimize Outcomes Webcast (2023)
Refractory Overactive Bladder: How to Select 3rd Line Therapies and Optimize Outcomes Webcast (2023)
CME Available: https://auau.auanet.org/node/38287
ACKNOWLEDGEMENTS
Independent educational grant support provided by:
Astellas
Urovant Sciences, Inc.